Jiangsu Nhwa Pharmaceutical Co Ltd

002262 • SHE

¥21.68+¥0.07 (0.32%)

Estimate

P/E

19.9

EPS

1.09

Beta

-0.307

Growth

Revenue, YoY

6.58%

Net income, YoY

5.56%

FCF, YoY

-68.47%

Forecast

P/E (FWD)

16.3

EPS (FWD)

1.33

Dividends

Dividend yield

1.85%

Annual payout

¥0.40

Next ex. div date

May 26, 27

Payout

34.2%

Div.growth, 5y

29.2%

Dividend growth streak

3 y

Div.rating

About the company

Ticker

002262

ISIN

CNE100000CG8

Country

China

Sector (GICS)

Healthcare

Jiangsu Nhwa Pharmaceutical Co., LTD engages in research, development, production, and sale of central nervous system products in China. The company offers APIs, solid preparation, water injection, and freeze-dried powder formulations for depression, anxiety disorders, insomnia, severe mental disorders, and neurodegenerative diseases. Its products include sufentanil citrate injection, oxaliplatin fumarate injection, alfentanil hydrochloride injection, oxycodone hydrochloride injection, olanzapine tablets, midazolam hydrochloride oral solution, clonazepam injection, lacosamide injection, micuronium injection, pregabalin capsules, vortioxetine hydrobromide tablets, tapentadone hydrochloride tablets, and oxycodone hydrochloride extended-release tablets. The company was founded in 1978 and is headquartered in Xuzhou, China.

Frequently asked questions

What sector does Jiangsu Nhwa Pharmaceutical Co Ltd (002262) operate in?

Jiangsu Nhwa Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Jiangsu Nhwa Pharmaceutical Co Ltd (002262) current stock price?

As of the latest data, Jiangsu Nhwa Pharmaceutical Co Ltd stock price is CN¥21.68, with a previous close of CN¥21.61. Jiangsu Nhwa Pharmaceutical Co Ltd gained CN¥0.07 in the last trading session, representing a 0.32% increase.

What is Jiangsu Nhwa Pharmaceutical Co Ltd (002262) current market capitalization?

Jiangsu Nhwa Pharmaceutical Co Ltd market cap is approximately 21.96 billion.

What is Jiangsu Nhwa Pharmaceutical Co Ltd (002262) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.09, and the forward EPS is CN¥1.33.

What is Jiangsu Nhwa Pharmaceutical Co Ltd (002262) Price-to-Earnings (P/E) ratio?

Jiangsu Nhwa Pharmaceutical Co Ltd current P/E ratio is 19.89, with a forward P/E of 16.3.

Does Jiangsu Nhwa Pharmaceutical Co Ltd (002262) pay dividends?

Yes. Jiangsu Nhwa Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 1.85% and an estimated annual payout of CN¥0.40 per share.

When is the next ex-dividend date for Jiangsu Nhwa Pharmaceutical Co Ltd (002262)?

The next ex-dividend date is scheduled for May 26, 2027.

How did Jiangsu Nhwa Pharmaceutical Co Ltd (002262) perform in its most recent earnings report?

In the last report (June 30, 2026), Jiangsu Nhwa Pharmaceutical Co Ltd posted an EPS surprise of -6.06% and a revenue surprise of -5.43%.

What is Jiangsu Nhwa Pharmaceutical Co Ltd (002262) beta (volatility) score?

Jiangsu Nhwa Pharmaceutical Co Ltd has a beta of -0.307, indicating lower volatility than the overall market.